Comparative Study of Through Knee Amputation Versus Above Knee Amputation Regarding Infection Rate and Function
Launched by ASSIUT UNIVERSITY · Apr 12, 2024
Trial Information
Current as of June 28, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at two different types of surgeries for people who need a knee amputation: through knee amputation (TKA) and above knee amputation (AKA). The researchers want to find out which method has better results in terms of healing, infection rates, and how well people can move around afterward. This study is not yet recruiting participants, but it's open to anyone who meets specific criteria, like having severe foot infections or major blood flow problems in their legs.
To be eligible for this trial, participants should have serious conditions such as critical limb ischemia with severe infection, which means their limb is not getting enough blood flow and is at risk. They are looking for individuals who have either an infected diabetic foot or traumatic gangrene but not those with venous gangrene. If you participate, you can expect to be closely monitored during the study to see how well you heal and recover functionally after the surgery.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Critical limb ischemia with sever infection with no role For BKA
- • Acute late or total ischemia SFA with poor
- • popliteal signals and no distal run off
- • Infected Diabetic foot (DF) affecting heel and calf muscle with preserved knee joint
- • Traumatic gangrene
- Exclusion Criteria:
- • Venous gangrene
About Assiut University
Assiut University, a prominent academic institution located in Egypt, is dedicated to advancing medical research and clinical trials that enhance healthcare outcomes. With a strong emphasis on innovation and collaboration, the university engages in a wide array of clinical studies across various disciplines, aiming to contribute valuable insights into disease prevention, diagnosis, and treatment. Assiut University's commitment to ethical research practices and rigorous scientific methodology ensures the integrity and reliability of its clinical trials, ultimately benefiting both the local community and the global medical landscape.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Trial Officials
Ahmed Mu Nagy
Study Director
Assiut University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported